Author:
Hong Jing,Wang Hang,Shen Guoying,Lin Da,Lin Yanxue,Ye Nanhui,Guo Yashan,Li Qiaoling,Ye Nanhui,Deng Chengjun,Meng Chun
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Forman, D. & Ferlay, J. In World cancer report, (eds Stewart, B. W. & Wild, C. P. ) 1–5 (International Agency for Research on Cancer, 2014).
2. Hytiroglou, P., Park, Y. N., Krinsky, G. & Theise, N. D. Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterology clin. North Am. 36, 867–887, vii (2007).
3. Liu, H. et al. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition. Carcinogenesis 36, 459–468 (2015).
4. Liu, Y., Fuchs, J., Li, C. & Lin, J. IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells. Cell cycle 9, 3423–3427 (2010).
5. Liu, Y., Li, P. K., Li, C. & Lin, J. Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells. J. Biol. Chem. 285, 27429–27439 (2010).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献